Enovix (NASDAQ:ENVX – Get Free Report) updated its third quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of -0.170–0.130 for the period, compared to the consensus EPS estimate of -0.150. The company issued revenue guidance of $9.0 million-$10.0 million, compared to the consensus revenue estimate of $10.3 million.
Wall Street Analysts Forecast Growth
ENVX has been the topic of a number of research analyst reports. Craig Hallum lowered their price objective on shares of Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Benchmark cut their target price on shares of Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. Wall Street Zen raised Enovix from a “strong sell” rating to a “sell” rating in a report on Saturday, May 16th. TD Cowen lowered their price target on Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a report on Friday, July 24th. Finally, Oppenheimer cut their price objective on Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a report on Thursday, May 14th. Six research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $12.50.
Read Our Latest Analysis on Enovix
Enovix Stock Performance
Enovix (NASDAQ:ENVX – Get Free Report) last announced its earnings results on Wednesday, August 12th. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.02. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The business had revenue of $9.02 million during the quarter, compared to analysts’ expectations of $8.43 million. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. Equities research analysts predict that Enovix will post -0.79 EPS for the current year.
Hedge Funds Weigh In On Enovix
A number of institutional investors have recently bought and sold shares of the stock. Parallel Advisors LLC increased its position in Enovix by 51.9% in the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after buying an additional 1,342 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Enovix during the 3rd quarter valued at approximately $80,000. Mercer Global Advisors Inc. ADV bought a new position in shares of Enovix during the 3rd quarter valued at approximately $100,000. Mackenzie Financial Corp purchased a new stake in Enovix in the 4th quarter worth approximately $77,000. Finally, CIBC Asset Management Inc purchased a new stake in Enovix in the 4th quarter worth approximately $78,000. 50.92% of the stock is owned by institutional investors.
Enovix Company Profile
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Featured Stories
- Five stocks we like better than Enovix
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
